203 related articles for article (PubMed ID: 23207185)
1. Multimodality treatment for early-stage hepatocellular carcinoma: a bridging therapy for liver transplantation.
Ashoori N; Bamberg F; Paprottka P; Rentsch M; Kolligs FT; Siegert S; Peporte A; Al-Tubaikh JA; D'Anastasi M; Hoffmann RT; Reiser MF; Jakobs TF
Digestion; 2012; 86(4):338-48. PubMed ID: 23207185
[TBL] [Abstract][Full Text] [Related]
2. Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.
Marin HL; Furth EE; Olthoff K; Shaked A; Soulen MC
J Gastrointestin Liver Dis; 2009 Jun; 18(2):169-76. PubMed ID: 19565046
[TBL] [Abstract][Full Text] [Related]
3. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list.
Fisher RA; Maluf D; Cotterell AH; Stravitz T; Wolfe L; Luketic V; Sterling R; Shiffman M; Posner M
Clin Transplant; 2004 Oct; 18(5):502-12. PubMed ID: 15344951
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
[TBL] [Abstract][Full Text] [Related]
5. Multimodality treatment with conventional transcatheter arterial chemoembolization and radiofrequency ablation for unresectable hepatocellular carcinoma.
Ashoori N; Paprottka P; Trumm C; Bamberg F; Kolligs FT; Rentsch M; Reiser MF; Jakobs TF
Digestion; 2012; 85(1):18-26. PubMed ID: 22156507
[TBL] [Abstract][Full Text] [Related]
6. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers.
Wong LL; Tanaka K; Lau L; Komura S
Clin Transplant; 2004 Jun; 18(3):227-34. PubMed ID: 15142041
[TBL] [Abstract][Full Text] [Related]
7. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.
Sotiropoulos GC; Malago M; Molmenti EP; Radtke A; Brokalaki EI; Nadalin S; Lang H; Frilling A; Baba HA; Kühl H; Verhagen R; Broelsch CE
Eur J Med Res; 2005 Dec; 10(12):539-42. PubMed ID: 16356871
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH
Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768
[TBL] [Abstract][Full Text] [Related]
9. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.
Heckman JT; Devera MB; Marsh JW; Fontes P; Amesur NB; Holloway SE; Nalesnik M; Geller DA; Steel JL; Gamblin TC
Ann Surg Oncol; 2008 Nov; 15(11):3169-77. PubMed ID: 18696158
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of superselective chemoembolization and radiofrequency ablation of hepatocellular carcinoma assessed in 21 explanted livers.
Lang EK; Brammer M; Charafeddine R; Regenstein F; Haque S; Florman S; Cline K; Slakey D
J La State Med Soc; 2008; 160(5):258-62. PubMed ID: 19048980
[TBL] [Abstract][Full Text] [Related]
11. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
[TBL] [Abstract][Full Text] [Related]
12. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.
Graziadei IW; Sandmueller H; Waldenberger P; Koenigsrainer A; Nachbaur K; Jaschke W; Margreiter R; Vogel W
Liver Transpl; 2003 Jun; 9(6):557-63. PubMed ID: 12783395
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial.
Peng ZW; Zhang YJ; Chen MS; Xu L; Liang HH; Lin XJ; Guo RP; Zhang YQ; Lau WY
J Clin Oncol; 2013 Feb; 31(4):426-32. PubMed ID: 23269991
[TBL] [Abstract][Full Text] [Related]
14. Role of transarterial chemoembolization for hepatocellular carcinoma before liver transplantation with special consideration of tumor necrosis.
Schaudt A; Kriener S; Schwarz W; Wullstein C; Zangos S; Vogl T; Mehrabi A; Fonouni H; Bechstein WO; Golling M
Clin Transplant; 2009 Dec; 23 Suppl 21():61-7. PubMed ID: 19930318
[TBL] [Abstract][Full Text] [Related]
15. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.
Lu DS; Yu NC; Raman SS; Lassman C; Tong MJ; Britten C; Durazo F; Saab S; Han S; Finn R; Hiatt JR; Busuttil RW
Hepatology; 2005 May; 41(5):1130-7. PubMed ID: 15841454
[TBL] [Abstract][Full Text] [Related]
17. Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization.
Wu F; Wang ZB; Chen WZ; Zou JZ; Bai J; Zhu H; Li KQ; Jin CB; Xie FL; Su HB
Radiology; 2005 May; 235(2):659-67. PubMed ID: 15858105
[TBL] [Abstract][Full Text] [Related]
18. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
Yao FY; Hirose R; LaBerge JM; Davern TJ; Bass NM; Kerlan RK; Merriman R; Feng S; Freise CE; Ascher NL; Roberts JP
Liver Transpl; 2005 Dec; 11(12):1505-14. PubMed ID: 16315294
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of hepatocellular carcinoma locoregional therapies on patients waiting for liver transplantation.
Moreno Planas JM; López Monclús J; Gómez Cruz A; Rubio González E; Pérez Arangüena R; Boullosa Graña E; Garcia Suárez A; Pérez-Picouto JL; Fernández Ruiz M; Lucena de la Poza JL; Sánchez Turrión V; Cuervas-Mons Martínez V
Transplant Proc; 2005 Apr; 37(3):1484-5. PubMed ID: 15866648
[TBL] [Abstract][Full Text] [Related]
20. Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients.
Huang ZM; Li W; Li S; Gao F; Zhou QM; Wu FM; He N; Pan CC; Xia JC; Wu PH; Zhao M
J Immunother; 2013 Jun; 36(5):287-93. PubMed ID: 23719239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
